Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design
- 1 April 2015
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 70, 140-151
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
This publication has 22 references indexed in Scilit:
- Analytical Solutions of Non-Linear Equations of Power-Law Fluids of Second Grade over an Infinite Porous PlateMathematical and Computational Applications, 2014
- Formulation and evaluation of thermoreversible, mucoadhesive in situ intranasal gel of rizatriptan benzoateJournal of Sol-Gel Science and Technology, 2014
- Duel-Acting Subcutaneous Microemulsion Formulation for Improved Migraine Treatment with Zolmitriptan and Diclofenac: Formulation and In Vitro-In Vivo CharacterizationThe AAPS Journal, 2013
- Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU)Acta Pharmaceutica, 2013
- Triptans for the Management of MigraineDrugs, 2010
- Formulation and evaluation of nasal mucoadhesive microspheres of Sumatriptan succinateJournal of Microencapsulation, 2009
- Mucoadhesive Vaginal Drug Delivery SystemsRecent Advances in Drug Delivery and Formulation, 2009
- Thermoreversible-mucoadhesive Gel for nasal delivery of sumatriptanAAPS PharmSciTech, 2006
- Temperature-responsive gels and thermogelling polymer matrices for protein and peptide deliveryAdvanced Drug Delivery Reviews, 1998
- Pre-clinical pharmacology of zolmitriptan (Zomig™; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraineCephalalgia, 1997